Computational Drug Delivery & Nanomedicine
Category VIEW ALL
Thermally Activated Ultrasound Contrast Agents
Technology No. 2019-SOLO-68683
Inhibiting Leukocyte Binding to Disfunctional Endothelial Cells
Technology No. 2014-PANI-66748
Collagen-Targeted Nanoparticles
Technology No. 65708
Multiscale Microdevices with Nanopillars for Antibiofouling Sensing and Drug Delivery
Technology No. 2018-LEE-68196
Spider Web-inspired Design for Three-dimensional Electronic Devices
Technology No. 2017-LEE-67683
Triggerable Oxygen Nanobubbles for Drug Delivery, Diagnosis, and Enhanced Survival
Technology No. 2015-IRUD-66920
Electromagnetic Drug Delivery Using EM Responsive Polypyrrole Nanowires
Technology No. 2014-BORG-66652
Designer Collagen Fibers for Tissue Engineering Applications
Technology No. 65081
P188 as a Treatment for Trauma to the Nervous System
Technology No. 61036
A Method for Encapsulation of Nanoparticles in Ionic Crystals
Technology No. 65679
Powder Blending and Segregation Model Subroutine Within Abaqus
Technology No. 2017-WASS-67839
Open Boundary Conditions for Quantum Models in Fluids
Technology No. 2017-KUBI-67787
Nontoxic Raman Tags for Study of Cell Functions
Technology No. 2014-CHEN-66885
Cleansing of Surfactant-Coated Nanoparticles
Technology No. 2014-WEI-66709
Poly(propylene carbonate)(PPC)-Based Amphiphilic Block Copolymers, and Methods of Use Thereof
Technology No. 2014-WON-66901
A New Low pH Gel-forming Soluble Polysaccharide
Technology No. 2019-HAMA-68698
Preparation of Highly Effectively Fusible Liposomes Reconstituted with Phage Portal Proteins for Nanopore Sensing Technology
Technology No. 2016-JING-67338
Calibration-free moisture content sensor and related methods
Technology No. 2024-LU-70552
Bacteriophage formulations
Technology No. 2025-ZHOU-70957
Gel forming polymers for improved oral peptide formulations
Technology No. 2025-TAYL-70925
Materials, methods and sampling devices for preserving and extracting extracellular vesicles in biofluids
Technology No. 2025-TAO-70811
carbonic anhydrase leads for treatment of bacterial infections
Technology No. 2025-FLAH-71261
Microwave Assisted Catalytic Amidation of Organic Amines with Carboxylic Acids
Technology No. 2024-THOM-70677
Enhanced immunotherapy of "cold" solid tumors using Tumor tropic S. Typhimurium expressing anti-cancer proteins
Technology No. 2024-HE-70612
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
3H-pyrazolo[4,3-f]quinoline-based Compounds as STING Antagonists
Technology No. 2023-SINT-70181
![3H-pyrazolo[4,3-f]quinoline-based Compounds as STING Antagonists](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13269/2/3h-pyrazolo43-fquinoline-based-compounds-as-sting-antagonists-01.png?mtime=20251201115737)
Designing HIV-1 Protease Inhibitors Using Imatinib & Nilotinib Templates for Effective HIV/AIDS Treatment
Technology No. 2023-GHOS-70150
CAR-neutrophils Produced In Vivo to Treat Cancer
Technology No. 2023-BAO-70025
Immunoactive Nanocarrier of Immunogenic Cell Death Inducers
Technology No. 2022-YEO-69546
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Continuous Flow Synthesis of Lorazepam
Technology No. 2022-THOM-69904
Plasticizers to Improve Release Performance of Amorphous Solid Dispersions
Technology No. 2022-TAYL-69586
Materials and Method to In Situ Isolate Phosphoproteins in Extracellular Vesicles and Exosome
Technology No. 2022-TAO-69815
Catalysis-Enabled Concise Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester
Technology No. 2022-DAI-69694
Inhibitors of Cyclic Mononucleotide and Cyclic Dinucleotide Phosphodiesterases
Technology No. 2021-SINT-69252
Novel inhalation formulations of polymyxins
Technology No. 2020-ZHOU-68990
Nano-composite Microparticles with Ivacaftor and Colistin
Technology No. 2020-ZHOU-68954
Quinolone-based Inhibitors of Lymphoid Tyrosine Phosphatase (PTPN22)
Technology No. 2020-ZHAN-68996
Custom G4 Microarrays can Determine a Large-scale Ligand Binding Selectivity
Technology No. 2020-YANG-69054
Activity-Based Probes with Unnatural Amino Acids to Monitor the Proteasome in Live Cells
Technology No. 2020-TRAD-68937
Tumbling Microrobots for in vivo Targeted Drug Delivery
Technology No. 2025-CAPP-70958
Long Acting Buprenorphine Implants
Technology No. 2024-OTTE-70416
Synthetic DNA nanopores for transmembrane delivery of biological material
Technology No. 2025-GREE-70808
Nanoparticle Formulation for Selective Delivery of Drugs to Cancer Cells
Technology No. 2023-HAN-70164
Selective Delivery of DNA Origami Nanostructures to Cancer Cells
Technology No. 2022-CHOI-69914
Machine Learning Analysis of Biotherapeutics
Technology No. 2024-ARDE-70506
